Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 3/20 | 0.36 |
| ▸ | DRD4 | P21917 | 3/20 | 0.36 |
| ▸ | DRD3 | P35462 | 3/20 | 0.36 |
| ▸ | G6PD | P11413 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | TDP2 | O95551 | 3/20 | 0.32 |
| ▸ | USP14 | P54578 | 2/20 | 0.32 |
| ▸ | RORC | P51449 | 2/20 | 0.32 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.32 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.32 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17877736 | 1.00 | KDM4E (0.39) | KDM4EATML3MBTL1DRD2DRD4 | |
| SCHEMBL17877849 | 1.00 | KDM4E (0.39) | KDM4EATML3MBTL1DRD2DRD4 | |
| SCHEMBL17877737 | 1.00 | KDM4E (0.39) | KDM4EATML3MBTL1DRD2DRD4 | |
| SCHEMBL17877872 | 0.96 | DRD2 (0.38) | KDM4EDRD2DRD4DRD3G6PD | |
| SCHEMBL17877905 | 0.96 | KDM4E (0.35) | KDM4EATML3MBTL1DRD2DRD4 | |
| SCHEMBL17877712 | 0.96 | KDM4E (0.35) | KDM4EATML3MBTL1DRD2DRD4 | |
| SCHEMBL17877877 | 0.92 | PRKDC (0.33) | KDM4EATML3MBTL1DRD2DRD4 | |
| SCHEMBL17877876 | 0.89 | PRKDC (0.32) | KDM4EATML3MBTL1DRD2DRD4 | |
| SCHEMBL17876318 | 0.88 | FLT3 (0.36) | DRD2DRD4DRD3CYP11B1CYP11B2 | |
| SCHEMBL17877878 | 0.88 | MYC (0.37) | KDM4EATML3MBTL1DRD2DRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160190482-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160190482-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNE2 | KDM4E 3120/4885ATM 1164/4885L3MBTL1 768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.